Ladenburg Thalmann Financial Services’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $22K | Sell |
33
-358
| -92% | -$239K | ﹤0.01% | 4107 |
|
2019
Q3 | $71K | Buy |
391
+6
| +2% | +$1.09K | ﹤0.01% | 3185 |
|
2019
Q2 | $51K | Buy |
385
+4
| +1% | +$530 | ﹤0.01% | 3454 |
|
2019
Q1 | $92K | Hold |
381
| – | – | ﹤0.01% | 2943 |
|
2018
Q4 | $72K | Sell |
381
-190
| -33% | -$35.9K | ﹤0.01% | 2996 |
|
2018
Q3 | $187K | Sell |
571
-20
| -3% | -$6.55K | ﹤0.01% | 2361 |
|
2018
Q2 | $143K | Hold |
591
| – | – | ﹤0.01% | 2490 |
|
2018
Q1 | $143K | Sell |
591
-18
| -3% | -$4.36K | ﹤0.01% | 2490 |
|
2017
Q4 | $184K | Buy |
609
+120
| +25% | +$36.3K | ﹤0.01% | 2267 |
|
2017
Q3 | $129K | Sell |
489
-14
| -3% | -$3.69K | ﹤0.01% | 2432 |
|
2017
Q2 | $132K | Buy |
503
+40
| +9% | +$10.5K | ﹤0.01% | 2336 |
|
2017
Q1 | $167K | Buy |
463
+20
| +5% | +$7.21K | ﹤0.01% | 2046 |
|
2016
Q4 | $128K | Buy |
443
+75
| +20% | +$21.7K | ﹤0.01% | 2129 |
|
2016
Q3 | $126K | Buy |
368
+41
| +13% | +$14K | ﹤0.01% | 2080 |
|
2016
Q2 | $139K | Sell |
327
-86
| -21% | -$36.6K | ﹤0.01% | 1919 |
|
2016
Q1 | $132K | Sell |
413
-52
| -11% | -$16.6K | ﹤0.01% | 1883 |
|
2015
Q4 | $241K | Sell |
465
-115
| -20% | -$59.6K | ﹤0.01% | 1456 |
|
2015
Q3 | $170K | Sell |
580
-6
| -1% | -$1.76K | ﹤0.01% | 1597 |
|
2015
Q2 | $230K | Buy |
586
+20
| +4% | +$7.85K | ﹤0.01% | 1513 |
|
2015
Q1 | $180K | Buy |
566
+26
| +5% | +$8.27K | ﹤0.01% | 1649 |
|
2014
Q4 | $120K | Buy |
+540
| New | +$120K | ﹤0.01% | 1782 |
|